You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

DrugPatentWatch Database Updates: New Patent Additions


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch Database Updates: New Patent Additions

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.
Glossary
Applicant Tradename Generic Name Dosage NDA Number Approval Date Type RLD Patent No. Product Substance Delist Requested Patent Expiration Date Submitted Usecode Patented / Exclusive Use
Springworks OGSIVEO nirogacestat hydrobromide TABLET 217677 001 Nov 27, 2023 RX Yes ⤷  Try a Trial Y ⤷  Try a Trial 2024-04-12
Springworks OGSIVEO nirogacestat hydrobromide TABLET 217677 001 Nov 27, 2023 RX Yes ⤷  Try a Trial Y ⤷  Try a Trial 2024-04-12 U-3754 TREATMENT OF ADULT PATIENTS WITH PROGRESSING DESMOID TUMORS
Springworks OGSIVEO nirogacestat hydrobromide TABLET 217677 001 Nov 27, 2023 RX Yes ⤷  Try a Trial Y ⤷  Try a Trial 2024-04-12 U-3754 TREATMENT OF ADULT PATIENTS WITH PROGRESSING DESMOID TUMORS
Springworks OGSIVEO nirogacestat hydrobromide TABLET 217677 001 Nov 27, 2023 RX Yes ⤷  Try a Trial Y ⤷  Try a Trial 2024-04-12
Springworks OGSIVEO nirogacestat hydrobromide TABLET 217677 001 Nov 27, 2023 RX Yes ⤷  Try a Trial Y ⤷  Try a Trial 2024-04-12 U-3754 TREATMENT OF ADULT PATIENTS WITH PROGRESSING DESMOID TUMORS
Springworks OGSIVEO nirogacestat hydrobromide TABLET 217677 001 Nov 27, 2023 RX Yes ⤷  Try a Trial Y ⤷  Try a Trial 2024-04-12 U-3754 TREATMENT OF ADULT PATIENTS WITH PROGRESSING DESMOID TUMORS
Springworks OGSIVEO nirogacestat hydrobromide TABLET 217677 001 Nov 27, 2023 RX Yes ⤷  Try a Trial Y ⤷  Try a Trial 2024-04-12
>Applicant >Tradename >Generic Name >Dosage >NDA >Number >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Requested >Patent Expiration >Date Submitted >Usecode >Patented / Exclusive Use

Subscribe to access the full database, or Try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group